Contents

What is the current state of patient experience in Uganda, the UK and the US – focusing on patient-centred care, physician perspectives and clinical research participation?

News about the latest roundup of clinical trials, including positive results from GSK for its phase 3 trial for cholestatic pruritus.

This section contains a roundup of some of the latest approvals, including news from Medicines and Healthcare products Regulatory Agency and the Scottish Medicines Constortium.

Sartorius Stedim announces the opening of a collaborative Center for Bioprocess Innovation in the US.

A double acquisition by Astoriom to improve its US and UK profiles.

Move of the month Veronica Gambrilla nominated as chair of the board of directors at MinervaX.

Our Team

Executive Director
PMGroup Worldwide Ltd
Karl Equi

Group Managing Editor
Iona Everson

Deputy Editor
Natalia Elliot
natalia@samedanltd.com

Business Manager
Louise Wilson-English
louise@samedanltd.com

Design & Layout
Peter May

Pharmafocus is published by:

Samedan Ltd
44 Maiden Lane, London
WC2E 7LN
Tel: +44 (0)20 7724 3456
Fax: +44 (0)20 7403 7747

Subscriptions & Data Management

Curwood CMS Tel: 01580 883840

ISSN: 1465-5403

Pharmafocus is sent free of charge to selected permanent employees of ethical and OTC pharmaceutical and biotech companies. Employees are specifiers from middle and senior management with responsibility for making buying decisions. Selection is at the discretion of the Publisher. Copies are also available on a subscription basis at an annual fee of £115 (UK), £145 (Europe) and £185 (RoW).

All subscriptions payable to Samedan. Back copies can be purchased for £15.00 each. Pharmafocus is published by Samedan Ltd. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form without permission, unless for the purposes of reference and comment.

©2024 Samedan Ltd, Pharmaceutical Publishers

The opinions and views expressed by contributors to this publication are not necessarily those of the Editor or the Publisher and, while every care has been taken in the preparation of the newspaper, the Editor and the Publisher are not responsible for such opinions and views, or for any inaccuracies in the articles. The Publisher is not responsible for any images supplied by contributors. While every care is taken with artwork supplied, the Publisher cannot be held responsible for any loss or damage incurred. The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form, by any means – electronic, mechanical, photocopying or otherwise – without the prior permission of the Publisher.